Blood Journal
Leading the way in experimental and clinical research in hematology

Malignant Cells Can Be Sensitized to Undergo Growth Inhibition and Apoptosis by Arsenic Trioxide Through Modulation of the Glutathione Redox System

  1. Jie Dai,
  2. Rona S. Weinberg,
  3. Samuel Waxman, and
  4. Yongkui Jing
  1. 1 From the Rochelle Belfer Chemotherapy Foundation Laboratory, the Division of Neoplastic Diseases, the Division of Hematology, the Department of Medicine, Mount Sinai Medical Center, New York, NY.

Abstract

Arsenic trioxide (As2O3) induces clinical remission in acute promyelocytic leukemia (APL) with minimal toxicity and apoptosis in APL-derived NB4 cells at low (1 to 2 μmol/L) concentration. We examined the basis for NB4 cell sensitivity to As2O3 to identify experimental conditions that would render other malignant cells responsive to low concentrations of As2O3. The intracellular glutathione (GSH) content had a decisive effect on As2O3-induced apoptosis. Highly sensitive NB4 cells had the lowest GSH and the sensitivity of other cell lines was inversely proportional to their GSH content. The t(14;18) B-cell lymphoma cell line had low GSH levels and sensitivity to As2O3 at levels slightly higher than in APL cells. Experimental upmodulation of GSH content decreased the sensitivity to As2O3. Ascorbic acid and buthionine sulfoxide (BSO) decreased GSH to a greater extent, and rendered malignant cells more sensitive to As2O3. As2O3-induced apoptosis was not enhanced by ascorbic acid in normal cells, suggesting that the combination of ascorbic acid and As2O3may be selectively toxic to some malignant cells. Ascorbic acid enhanced the antilymphoma effect of As2O3 in vivo without additional toxicity. Thus, As2O3alone or administered with ascorbic acid may provide a novel therapy for lymphoma.

  • Submitted February 19, 1998.
  • Accepted August 24, 1998.
View Full Text